GlaxoSmithKline PLC Base prospectus re £15bn EMTN programme (1341N)
August 04 2017 - 3:06AM
UK Regulatory
TIDMGSK
RNS Number : 1341N
GlaxoSmithKline PLC
04 August 2017
Publication of Base Prospectus
The following base prospectus dated 3 August 2017 has been
approved by the UK Listing Authority and is available for
viewing:
GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital
K.K. GBP15,000,000,000 Euro Medium Term Note Programme
Copies of the base prospectus and the documents incorporated by
reference within it have been submitted to the National Storage
Mechanism and will shortly be available for inspection at and can
be downloaded from:
www.morningstar.co.uk/uk/NSM
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
UK Media enquiries: David Mawdsley (020) 8047 5564
Simon Steel (020) 8047 3763
European Analyst/Investor (020) 8047
enquiries: James Dodwell 2406
(020) 8047
Craig Haffey 6313
BASIS ON WHICH YOU MAY ACCESS THE BASE PROSPECTUS
Please note that the information contained in the base
prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the base
prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the base prospectus is not addressed. Prior
to relying on the information contained in the base prospectus you
must ascertain from the base prospectus whether or not you are part
of the intended addressees of the information contained
therein.
Your right to access this service is conditional upon complying
with the above requirements.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PDIUGUUURUPMURC
(END) Dow Jones Newswires
August 04, 2017 04:06 ET (08:06 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024